In 2022, approximately 15 percent of all women in Mississippi had been diagnosed with diabetes. This statistic displays rates of diagnosed diabetes among women in the U.S. in 2022.

The goal of the Chicago Women's Health Risk Study (CWHRS) was to develop a reliable and validated profile of risk factors directly related to lethal or life-threatening outcomes in intimate partner violence, for use in agencies and organizations working to help women in abusive relationships. Data were collected to draw comparisons between abused women in situations resulting in fatal outcomes and those without fatal outcomes, as well as a baseline comparison of abused women and non-abused women, taking into account the interaction of events, circumstances, and interventions occurring over the course of a year or two. The CWHRS used a quasi-experimental design to gather survey data on 705 women at the point of service for any kind of treatment (related to abuse or not) sought at one of four medical sites serving populations in areas with high rates of intimate partner homicide (Chicago Women's Health Center, Cook County Hospital, Erie Family Health Center, and Roseland Public Health Center). Over 2,600 women were randomly screened in these settings, following strict protocols for safety and privacy. One goal of the design was that the sample would not systematically exclude high-risk but understudied populations, such as expectant mothers, women without regular sources of health care, and abused women in situations where the abuse is unknown to helping agencies. To accomplish this, the study used sensitive contact and interview procedures, developed sensitive instruments, and worked closely with each sample site. The CWHRS attempted to interview all women who answered "yes -- within the past year" to any of the three screening questions, and about 30 percent of women who did not answer yes, provided that the women were over age 17 and had been in an intimate relationship in the past year. In total, 705 women were interviewed, 497 of whom reported that they had experienced physical violence or a violent threat at the hands of an intimate partner in the past year (the abused, or AW, group). The remaining 208 women formed the comparison group (the non-abused, or NAW, group). Data from the initial interview sections comprise Parts 1-8. For some women, the AW versus NAW interview status was not the same as their screening status. When a woman told the interviewer that she had experienced violence or a violent threat in the past year, she and the interviewer completed a daily calendar history, including details of important events and each violent incident that had occurred the previous year. The study attempted to conduct one or two follow-up interviews over the following year with the 497 women categorized as AW. The follow-up rate was 66 percent. Data from this part of the clinic/hospital sample are found in Parts 9-12. In addition to the clinic/hospital sample, the CWHRS collected data on each of the 87 intimate partner homicides occurring in Chicago over a two-year period that involved at least one woman age 18 or older. Using the same interview schedule as for the clinic/hospital sample, CWHRS interviewers conducted personal interviews with one to three "proxy respondents" per case, people who were knowledgeable and credible sources of information about the couple and their relationship, and information was compiled from official or public records, such as court records, witness statements, and newspaper accounts (Parts 13-15). In homicides in which a woman was the homicide offender, attempts were made to contact and interview her. This "lethal" sample, all such homicides that took place in 1995 or 1996, was developed from two sources, HOMICIDES IN CHICAGO, 1965-1995 (ICPSR 6399) and the Cook County Medical Examiner's Office. Part 1 includes demographic variables describing each respondent, such as age, race and ethnicity, level of education, employment status, screening status (AW or NAW), birthplace, and marital status. Variables in Part 2 include details about the woman's household, such as whether she was homeless, the number of people living in the household and details about each person, the number of her children or other children in the household, details of any of her children not living in her household, and any changes in the household structure over the past year. Variables in Part 3 deal with the woman's physical and mental health, including pregnancy, and with her social support network and material resources. Variables in Part 4 provide information on the number and type of firearms in the household, whether the woman had experienced power, control, stalking, or harassment at the hands of an intimate partner in the past year, whether she had experienced specific types of violence or violent threats at the hands of an intimate partner in the past year, and whether she had experienced symptoms of Post-Traumatic Stress Disorder related to the incidents in the past month. Variables in Part 5 specify the partner or partners who were responsible for the incidents in the past year, record the type and length of the woman's relationship with each of these partners, and provide detailed information on the one partner she chose to talk about (called "Name"). Variables in Part 6 probe the woman's help-seeking and interventions in the past year. Variables in Part 7 include questions comprising the Campbell Danger Assessment (Campbell, 1993). Part 8 assembles variables pertaining to the chosen abusive partner (Name). Part 9, an event-level file, includes the type and the date of each event the woman discussed in a 12-month retrospective calendar history. Part 10, an incident-level file, includes variables describing each violent incident or threat of violence. There is a unique identifier linking each woman to her set of events or incidents. Part 11 is a person-level file in which the incidents in Part 10 have been aggregated into totals for each woman. Variables in Part 11 include, for example, the total number of incidents during the year, the number of days before the interview that the most recent incident had occurred, and the severity of the most severe incident in the past year. Part 12 is a person-level file that summarizes incident information from the follow-up interviews, including the number of abuse incidents from the initial interview to the last follow-up, the number of days between the initial interview and the last follow-up, and the maximum severity of any follow-up incident. Parts 1-12 contain a unique identifier variable that allows users to link each respondent across files. Parts 13-15 contain data from official records sources and information supplied by proxies for victims of intimate partner homicides in 1995 and 1996 in Chicago. Part 13 contains information about the homicide incidents from the "lethal sample," along with outcomes of the court cases (if any) from the Administrative Office of the Illinois Courts. Variables for Part 13 include the number of victims killed in the incident, the month and year of the incident, the gender, race, and age of both the victim and offender, who initiated the violence, the severity of any other violence immediately preceding the death, if leaving the relationship triggered the final incident, whether either partner was invading the other's home at the time of the incident, whether jealousy or infidelity was an issue in the final incident, whether there was drug or alcohol use noted by witnesses, the predominant motive of the homicide, location of the homicide, relationship of victim to offender, type of weapon used, whether the offender committed suicide after the homicide, whether any criminal charges were filed, and the type of disposition and length of sentence for that charge. Parts 14 and 15 contain data collected using the proxy interview questionnaire (or the interview of the woman offender, if applicable). The questionnaire used for Part 14 was identical to the one used in the clinic sample, except for some extra questions about the homicide incident. The data include only those 76 cases for which at least one interview was conducted. Most variables in Part 14 pertain to the victim or the offender, regardless of gender (unless otherwise labeled). For ease of analysis, Part 15 includes the same 76 cases as Part 14, but the variables are organized from the woman's point of view, regardless of whether she was the victim or offender in the homicide (for the same-sex cases, Part 15 is from the woman victim's point of view). Parts 14 and 15 can be linked by ID number. However, Part 14 includes five sets of variables that were asked only from the woman's perspective in the original questionnaire: household composition, Post-Traumatic Stress Disorder (PTSD), social support network, personal income (as opposed to household income), and help-seeking and intervention. To avoid redundancy, these variables appear only in Part 14. Other variables in Part 14 cover information about the person(s) interviewed, the victim's and offender's age, sex, race/ethnicity, birthplace, employment status at time of death, and level of education, a scale of the victim's and offender's severity of physical abuse in the year prior to the death, the length of the relationship between victim and offender, the number of children belonging to each partner, whether either partner tried to leave and/or asked the other to stay away, the reasons why each partner tried to leave, the longest amount of time each partner stayed away, whether either or both partners returned to the relationship before the death, any known physical or emotional problems sustained by victim or offender, including the four-item Medical Outcomes Study (MOS) scale of depression, drug and alcohol use of the victim and offender, number and type of guns in the household of the victim and offender, Scales of Power and Control (Johnson, 1996) or Stalking and Harassment (Sheridan, 1992) by either intimate partner in the year prior to the death, a modified version of the Conflict Tactics Scale (CTS)

Women's health funding by the NIH was around 4.6 billion U.S. dollars during fiscal year 2023. This graph shows the actual women's health funding by the National Institutes for Health (NIH) from FY 2013 to FY 2023 and estimates for FY 2024 and FY 2025.

The global women's health market was valued at USD 24.6 billion in 2025 and is expected to grow at a CAGR of 6.4% during the forecast period, reaching USD 38.0 billion by 2033. Rising prevalence of women-centric health issues, such as breast cancer, cervical cancer, and cardiovascular diseases, along with increasing awareness about these conditions are the primary drivers of market growth. Furthermore, technological advancements in diagnostic and treatment modalities, coupled with government initiatives aimed at improving access to healthcare for women, are further propelling market expansion. North America held the largest market share in 2025, due to the presence of well-established healthcare infrastructure, high healthcare spending, and a growing geriatric population. The Asia Pacific region is projected to witness the highest growth during the forecast period, driven by increasing disposable income, rising awareness about women's health issues, and government initiatives focused on improving healthcare access in developing countries. Key market participants include Amgen, Bayer, Merck KGaA, Merck & Co., Ferring, Eli Lilly, Pfizer, AbbVie, Abbott, and Theramex. These companies are actively engaged in research and development to introduce innovative products and expand their product portfolios, thereby contributing to the overall growth of the women's health market.

In 2022, six in ten percent of women aged 19 to 64 had employer-sponsored insurance coverage, while another ten percent had health coverage via Medicaid. This statistic depicts the percentage of U.S. women between the ages of 19 and 64 years with health insurance coverage in 2022, by coverage type.

The Study of Women's Health Across the Nation (SWAN) is a multi-site longitudinal, epidemiologic study designed to examine the health of women during their middle years. The study examines the physical, biological, psychological and social changes during this transitional period. The goal of SWAN's research is to help scientists, health care providers and women learn how mid-life experiences affect health and quality of life during aging. Data were collected about doctor visits, medical conditions, medications, treatments, medical procedures, relationships, smoking, and menopause related information such as age at pre-, peri- and post-menopause, self-attitudes, feelings, and common physical problems associated with menopause. The study began in 1994. Between 2006 and 2008, 2,245 of the 3,302 women that joined SWAN were seen for their tenth follow-up visit. The research centers are located in the following communities: Ypsilanti and Inkster, MI (University of Michigan), Boston, MA (Massachusetts General Hospital), Chicago, IL (Rush Presbyterian-St. Luke's Medical Center), Almaeda and Contra Costa County, CA (University of California, Davis and Kaiser Permanente), Los Angeles, CA (University of California, Los Angeles), Hackensack, NJ (Hackensack University Medical Center) and Pittsburgh, PA (University of Pittsburgh). SWAN participants represent five racial/ethnic groups and a variety of backgrounds and cultures. Though the New Jersey site was still part of the study, data was not collected from this site for the tenth visit. Demographic and background information includes age, language of interview, marital status, household composition, and employment.

The SWAN Public Use Datasets provide access to longitudinal data describing the physical, biological, psychological, and social changes that occur during the menopausal transition. Data collected from 3,302 SWAN participants from Baseline through the 10th Annual Follow-Up visit are currently available to the public. Registered users are able to download datasets in a variety of formats, search variables and view recent publications.

This blog post was posted by Winifred Rossi on May 6, 201.

Users can access data related to international women’s health as well as data on population and families, education, work, power and decision making, violence against women, poverty, and environment. Background World’s Women Reports are prepared by the Statistics Division of the United Nations Department for Economic and Social Affairs (UNDESA). Reports are produced in five year intervals and began in 1990. A major theme of the reports is comparing women’s situation globally to that of men in a variety of fields. Health data is available related to life expectancy, cause of death, chronic disease, HIV/AIDS, prenatal care, maternal morbidity, reproductive health, contraceptive use, induced abortion, mortality of children under 5, and immunization. User functionality Users can download full text or specific chapter versions of the reports in color and black and white. A limited number of graphs are available for download directly from the website. Topics include obesity and underweight children. Data Notes The report and data tables are available for download in PDF format. The next report is scheduled to be released in 2015. The most recent report was released in 2010.

International Journal of Womens Health Acceptance Rate - ResearchHelpDesk - The International Journal of Women's Health (ISSN: 1179-1411) is a peer-reviewed healthcare journal focusing on all aspects of women's health care, including gynecology, obstetrics, and breast cancer. Abstracted &Indexing Details: PubMed and PubMed Central (Int J Womens Health) Emerging Sources Citation Index (ESCI), from 2016 Embase, from 2009 (Correct as at December 8, 2016) Scopus, from 2009 (Correct as at December 8, 2016) OAIster - The Open Access Initiative Directory of Open Access Journals (DOAJ) The journal is published by Dove Medical Press.

In 2024, almost every second Polish woman struggled with painful periods.

This special topic poll, fielded May 19-22, 1997, is part of a continuing series of monthly surveys that solicit public opinion on the presidency and on a range of other political and social issues. The focus of this data collection was men's and women's health issues. Respondents were asked about health-related topics such as what they thought was the leading cause of death for women, the perceived differences in men's and women's health and their interactions with their doctors, what they thought were the most serious diseases or medical problems facing the country, and whether they thought the federal government spends more money researching health problems as they relate to men or more money researching health problems as they relate to women. Female respondents were polled on whether a doctor had ever discussed mammograms with them, whether they ever had a mammogram, how trustworthy, safe, and painful mammograms were, at which age women should begin getting mammograms, and how often they conducted breast self-examinations. All respondents were asked whether they tried alternative medicine, whether they had considered trying alternative medicine, and whether they would choose alternative medicine instead of traditional medicine. A series of questions were asked about the type of interactions respondents had with their doctors such as whether respondents felt intimidated by their doctors, how comfortable respondents felt asking their doctors a lot of questions, whether respondents thought their doctors spoke down to them, and whether respondents usually call their doctors by their first name. Respondent's views were also sought on other topics such as the respondent's state of health, menopause, and hormone replacement therapy. Demographic variables included sex, age, race, education level, employment status, presence of children and teenagers in the household, household income, marital status, political party affiliation, political philosophy, type of residential area (e.g., urban or rural), and religious preference.

By 2027, it was forecast that the subsection focused on women's chronic conditions would be worth 218 billion U.S. dollars globally, the highest value of all the subsections. Furthermore, the women's reproductive health market was forecast to reach a size of 171 billion U.S. dollars by 2027.

Financial overview and grant giving statistics of Womens Health and Education Fund

Financial overview and grant giving statistics of Womens Health Center of West Virginia Inc.

The SWAN Coordinating Center provides SWAN data access to SWAN Investigators through the study website. The SWAN website provides access to longitudinal data describing the physical, biological, psychological, and social changes that occur during the menopausal transition. Data collected from 3,302 SWAN participants from Baseline through the 13th Follow-Up visit are currently available.

Financial overview and grant giving statistics of Feminist Womens Health Center

The statistic shows the size of the women's health drugs and devices market worldwide in 2016 and a forecast for 2023, measured in billion U.S. dollars. In 2016, the total global market was valued around 31 billion U.S. dollars. It is estimated that the market will grow to some 42 billion dollars by 2023.

Financial overview and grant giving statistics of Womens Health Project Inc.

Snapshot img

Womens Health Diagnostics Market Size 2024-2028

The womens health diagnostics market size is forecast to increase by USD 14.61 billion at a CAGR of 8.09% between 2023 and 2028.

The women's health diagnostics market is experiencing significant growth due to several key factors. The increasing prevalence of breast cancer worldwide is driving market demand, as early and accurate medical diagnostics is crucial for effective treatment. 
Another trend is the global adoption of advanced diagnostic solutions, which offer improved accuracy and efficiency compared to traditional methods. Stringent regulatory bodies are also guiding manufacturers of in-vitro diagnostics to ensure product safety and quality, further boosting market growth. These factors are expected to continue shaping the women's health diagnostics market In the coming years.

What will be the Size of the Womens Health Diagnostics Market During the Forecast Period?

Request Free Sample

The Women's Health Diagnostics Market encompasses a range of medical diagnostic devices and techniques aimed at detecting various conditions unique to women. Key diseases include breast, ovarian, and cervical cancers, as well as infectious diseases such as hepatitis and urinary tract infections. Diagnostic methods span imaging techniques like Breast MRI and ultrasound, bone density testing for osteoporosis, and breast cancer biopsy devices for cancer diagnosis. 
The geriatric female population is a significant market driver, given the increased prevalence of chronic conditions like cancer and osteoporosis. Medical science continues to advance, leading to the development of more sophisticated diagnostic tools and tests for pregnancy and menopause.
The market also caters to infectious diseases, with a growing focus on HIV/AIDS and other sexually transmitted infections. Overall, the Women's Health Diagnostics market is a vital sector in healthcare, providing essential tools for early detection and effective treatment of various conditions.

How is this Womens Health Diagnostics Industry segmented and which is the largest segment?

The womens health diagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Breast cancer testing
  Infectious disease testing
  STD testing
  Cervical cancer testing
  Others


End-user

  Hospitals and clinics
  Diagnostic and imaging centers
  Home care settings


Geography

  North America

    Canada
    US


  Europe

    UK
    France


  Asia

    China


  Rest of World (ROW)

By Application Insights

The breast cancer testing segment is estimated to witness significant growth during the forecast period.

Women's health diagnostics encompass various medical tests and devices used to identify and manage conditions such as breast cancer, ovarian cancer, cervical cancer, menopause, pregnancy, and chronic conditions like osteoporosis and infectious diseases. Breast cancer diagnosis primarily relies on biopsy procedures, where a specialized needle and imaging techniques, such as mammography or ultrasound, guide the doctor to extract tissue samples for laboratory analysis. Biopsy devices, ultrasound devices, mammography systems, and diagnostic tests are essential medical diagnostics tools. The geriatric female population, hospitals and clinics, diagnostic centers, and home care settings utilize these devices. Diagnostic tests for breast cancer, cervical cancer, ovarian cancer, prenatal genetic screening, and infectious diseases like hepatitis, urinary tract infection, and HIV/AIDS are crucial.

Medical science advances continue to introduce new technologies, such as bone density testing, MRI, and genomic testing, to enhance diagnostic accuracy and patient care. Healthcare expenditure on diagnostic devices, accessories, and consumables is significant, with emerging countries increasingly investing in these technologies.

Get a glance at the Womens Health Diagnostics Industry report of share of various segments Request Free Sample

The Breast cancer testing segment was valued at USD 6.56 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

In North America, the adoption of advanced diagnostic technologies for women's health has been on the rise due to increasing healthcare expenditure, growing awareness about chronic diseases such as breast, ovarian, and cervical cancer, and the